1. Home
  2. GOLF vs TVTX Comparison

GOLF vs TVTX Comparison

Compare GOLF & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acushnet Holdings Corp.

GOLF

Acushnet Holdings Corp.

HOLD

Current Price

$89.19

Market Cap

5.0B

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$46.20

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOLF
TVTX
Founded
1910
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.1B
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
GOLF
TVTX
Price
$89.19
$46.20
Analyst Decision
Hold
Strong Buy
Analyst Count
7
13
Target Price
$83.67
$40.62
AVG Volume (30 Days)
314.2K
2.0M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
1.07%
N/A
EPS Growth
N/A
92.89
EPS
1.36
N/A
Revenue
$1,633,721,000.00
N/A
Revenue This Year
$5.76
$44.76
Revenue Next Year
$2.44
$35.51
P/E Ratio
$65.43
N/A
Revenue Growth
4.71
N/A
52 Week Low
$69.54
$13.88
52 Week High
$104.81
$48.61

Technical Indicators

Market Signals
Indicator
GOLF
TVTX
Relative Strength Index (RSI) 46.30 58.73
Support Level $88.33 $41.43
Resistance Level $92.18 $48.60
Average True Range (ATR) 2.22 2.02
MACD 0.35 -0.24
Stochastic Oscillator 55.39 65.70

Price Performance

Historical Comparison
GOLF
TVTX

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: